insights_auto
Why is NEU down 5.08%?
Dive Deeperchevron_right
NEU:ASX
Neuren Pharmaceuticals Ltd
A$18.58
arrow_downward
-5.08%(-1.00) 1D
Oct 26, 3:23:24 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$19.40
High
A$19.40
Low
A$18.58
Mkt. cap
2.36B
Avg. vol.
329.60K
Volume
257.70K
Dividend
0.81%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
120.39
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$19.40
High
A$19.40
Low
A$18.58
Mkt. cap
2.36B
Avg. vol.
329.60K
Volume
257.70K
Dividend
0.81%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
120.39
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
bloomingbit
·
38 minutes ago
Hong Kong Names Nasdaq-Listed Solana Company Strategic Enterprise to Support Blockchain Infrastructure
TradingView
·
2 hours ago
Nasdaq Futures Slip Amid Tech Selloff While S&P 500, Dow Edge Higher Ahead Of Crucial Earnings Week: IREN, CRWV, NBIS, MRNA, EWZ In Focus
Cryptonews.net
·
16 minutes ago
Hong Kong names Nasdaq-listed Solana Company a strategic enterprise
Bloomberg.com
·
14 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com